Serina Therapeutics
0 followers
SER
Performance
About Serina Therapeutics
Serina Therapeutics is a biotechnology company focused on polymer-based drug optimization to improve how small molecule therapeutics perform in the body. Its POZ Platform enables precise, controlled, and sustained exposure of proven drugs, with a lead program around SER-252 (POZ-apomorphine) for advanced Parkinson’s disease. The company emphasizes biopharmaceutical innovations that allow less frequent, at-home injections and aim to shorten time to market through the 505(b)(2) regulatory pathway. Based in the United States, Serina targets CNS indications and partnerships to advance next-generation formulations of established therapies.
Recent News
No recent news for this company.
Recent Deals
No recent deals for this company.